NPM1 and acute myeloid leukemia: Since our MRD samples were from NPM1 mutated diagnosis samples, we trained the random forest only on the NPM1-positive AML first diagnosis samples, but this did not increase the anomaly detection in MRD positive or negative samples (Supplemental Fig. S13).